TMThiago De Marchi

Thiago De Marchi

*This is an algorithmically generated author record based on publicly available information.

Thiago De Marchi has a total of 85 co-authors. Here are the top co-authors by number of shared publications:

  • Ernesto Cesar Pinto Leal-Junior

    Laboratory of Phototherapy and Innovative Technologies in Health (LaPIT), Postgraduate Program in Rehabilitation Sciences, Nove de Julho University (UNINOVE), São Paulo, Brazil

    11 shared publications
  • Shaiane Silva Tomazoni

    Laboratory of Phototherapy and Innovative Technologies in Health (LaPIT), Post-graduate Program in Rehabilitation Sciences, Nove de Julho University, São Paulo, São Paulo, Brazil

    6 shared publications
  • João Vitor Ferlito

    Center University UniFtec Bento Gonçalves, Bento Gonçalves, Brazil; Oxidative Stress and Antioxidants Laboratory, University of Caxias Do Sul, Caxias do Sul, Brazil

    4 shared publications
  • Mirian Salvador

    Laboratory of Oxidative Stress and Antioxidants, Biotechnology Institute, University of Caxias do Sul, Caxias do Sul, RS, Brazil

    3 shared publications
  • Adriane Aver Vanin

    Masters and Doctoral Programs in Physical Therapy, Universidade Cidade de São Paulo, Sao Paulo, Brazil

    2 shared publications
  • Caroline dos Santos Monteiro Machado

    Laboratory of Phototherapy and Innovative Technologies in Health (LaPIT), Postgraduate Program in Rehabilitation Sciences, Nove de Julho University, Sao Paulo, Brazil

    2 shared publications

Latest Publications

  • Open Access

    High-Power Laser Therapy Modulates Mitochondrial Function and Redox Balance Without Cytotoxicity: An In Vitro Study in BV-2 Microglial Cells

    by Luana Barbosa Dias, Thiago De Marchi, Ana Paula Vargas Visentin, Juliana Maria Chaves, Catia Santos Branco, Fernando Joel Scariot, Matheus Marinho Aguiar Lino, Older Manoel Araújo-Silva, Amanda Lima Pereira, Heliodora Leão Casalechi, et al.

    Background: Recent technological advances have sparked growing interest in high-power laser devices due to their capacity for energy delivery and therapeutic potential, especially in deeper tissues. This promising approach may be comparable to photobiomodulation for modulating inflammatory and redox processes in various tissues. However, to our knowledge, this is the first study to evaluate the safety profile and redox modulation capacity of high-power laser therapy in BV-2 microglial cells. Methods: This study investigated the cellular responses of BV-2 microglial cells exposed to three laser irradiation protocols using a high-power laser device (650/810/915/980 nm, 657 J total dose), applied at variable distances to simulate in vivo power attenuation. Cell viability, apoptosis, adenosine triphosphate(ATP) levels, mitochondrial membrane potential (MMP), reactive oxygen species (ROS), nitric oxide (NO), and intracellular calcium levels were assessed at multiple time points (5 min to 24 h). Results: Protocol-dependent effects were observed. Protocol A promoted early increases in cell viability and ATP levels, along with decreased apoptotic markers and ROS production, suggesting a protective bioenergetic response. In contrast, Protocol C showed transient increases in oxidative stress and reduced MMP, suggesting possible mitochondrial stress. A selective increase in NO levels under Protocol A also suggests modulation of inflammatory pathways without cytotoxicity. Conclusions: High-power laser therapy modulates redox balance, mitochondrial function, and inflammatory mediators (e.g., NO) in a dual-phase manner in BV-2 microglial cells. These findings contribute to defining safe and effective parameters for potential musculoskeletal and neurological applications.


  • Open Access

    Acute Effects of Photobiomodulation Therapy Combined with Static Magnetic Field in C2C12 Muscle Cells Exposed and Not Exposed to H2O2

    by Marcos Vinicius Ferlito, João Vitor Ferlito, Fernando Joel Scariot, Mirian Salvador, Ernesto Cesar Pinto Leal-Junior, Thiago De Marchi, Catia Santos Branco

    Photobiomodulation (PBM) has been applied in biomedical technology to improve cellular responses. Specifically in sports medicine, it is used to accelerate metabolic and structural repair and adaptation in skeletal muscle under stress overload. Currently, PBM has been associated with static Magnetic Field (sMF) in clinical applications, enhancing the effects displayed by PBM when used in isolation. However, the biochemical and molecular effects of PBM-sMF in myoblasts remain unknown. This study aimed to investigate the effects of PBM combined with static magnetic field (PBM-sMF) at different doses in C2C12 muscle cells in the presence or absence of hydrogen peroxide (H2O2), a standard oxidant. Different spectrophotometric and fluorometric assays were conducted after cellular treatments. PBM-sMF was shown to be effective compared to H2O2 regarding cell viability and release of nitric oxide (NO), dsDNA, and reactive oxygen species (ROS) levels. It positively modulated mitochondrial membrane potential (ΔΨm) and cytochrome c oxidase (COX) activity under normal conditions and restored both to normal levels when impacted by H2O2. Regarding apoptosis, the recovery in viable cells observed on PBM-sMF treated cells was dose-dependent. In conclusion, PBM-sMF has a biphasic effect in normal and oxidative environments and may differently modulate myoblast cells depending on their redox status.


  • Open Access

    Pilates Method and/or Photobiomodulation Therapy Combined to Static Magnetic Field in Women with Stress Urinary Incontinence: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    by Thiago De Marchi, João Vitor Ferlito, Ariane Cristina Turra, Sheila Flamia, Franciele de Bispo Magro, Maribel Luiza Pavelecini Donida, Michele Dilkin, Djéssica da Silva, Vanessa Massia Ribas, Ernesto Cesar Pinto Leal Junior

    This clinical trial aims to provide evidence about the effectiveness of the Pilates method on stress urinary incontinence (SUI), as well as to elucidate the effects of photobiomodulation therapy associated with static magnetic field (PBMT/sMF) alone or associated with the Pilates Method on Pelvic floor muscle (PFM) in women affected by SUI. For that, a three-arm, parallel randomized, double-blinded, placebo-controlled trial was conducted (NCT05096936). We recruited thirty-three women diagnosed with SUI, randomly allocated to three groups: placebo PBMT/sMF plus method Pilates, PBMT/sMF active plus method Pilates and only PBMT/sMF active. The evaluation consisted of anamnesis and physical examination, muscle strength, completion of the ICIQ-SF questionnaire, and urinary loss. The evaluation of muscle strength and filling the ICIQ-SF were performed on the first and last days, while the Pad test was applied in baseline, one month, two months, and three months of intervention. We observed an increase in strength (p < 0.01), tone (p < 0.01), and quality of life (p < 0.01), in addition to a decrease in urinary lost (p < 0.01) for all groups comparing the pre and post-intervention. The PBMT/sMF alone, the Pilates, and the combination of the two therapies proved to be effective in improving the signs and symptoms of women with SUI.


  • Open Access

    Photobiomodulation Therapy Combined with a Static Magnetic Field Applied in Different Moments Enhances Performance and Accelerates Muscle Recovery in CrossFit® Athletes: A Randomized, Triple‐Blind, Placebo‐Controlled Crossover Trial

    by Henrique Dantas Pinto, Heliodora Leão Casalechi, Thiago de Marchi, Caroline dos Santos Monteiro Machado, Luana Barbosa Dias, Matheus Marinho Aguiar Lino, Jonatas Bezerra de Azevedo, Shaiane Silva Tomazoni, Ernesto Cesar Pinto Leal-Junior

    The ergogenic effects of photobiomodulation therapy combined with a static magnetic field (PBMT‐sMF) on exercises with characteristics similar to those of CrossFit® are unknown. This study was aimed at investigating the effects of PBMT‐sMF applied at different times on recovery and physical performance in CrossFit® athletes by analyzing functional aspects, muscle damage, inflammatory processes, and oxidative stress. This was a prospectively registered, triple‐blinded, placebo‐controlled, crossover trial. CrossFit® athletes were recruited and assigned to receive one of the four possible interventions. Each intervention included protocols before and after the exercise (referred to as the workout of the day (WOD)). The four possibilities of intervention were as follows: placebo before and after WOD (placebo), PBMT‐sMF before and placebo after WOD (PBMT‐sMF before), placebo before and PBMT‐sMF after WOD (PBMT‐sMF after), and PBMT‐sMF before and after WOD (PBMT‐sMF before and after). The order of possibilities for the interventions was randomized. The primary outcome was the functional test performance. The secondary outcomes were the subjective perception of exertion, muscle damage, inflammation, and oxidative stress. The outcomes were measured before the WOD; immediately after the intervention; and 1, 24, and 48 hours after the WOD. Statistical analysis was performed using repeated measures ANOVA followed by the Bonferroni post hoc test to examine the differences between the interventions at each time point. Twelve participants were randomized and analyzed for each sequence. PBMT‐sMF enhanced the performance on functional tests (calculated as a percentage of change) when applied before or after WOD in the assessment performed immediately post‐WOD and at 24 and 48 hours later (p < 0.05) compared to placebo and PBMT‐sMF before and after WOD. In terms of the secondary outcomes, PBMT‐sMF applied before or after WOD significantly decreased the creatine kinase, catalase, and superoxide dismutase activities and interleukin‐6, thiobarbituric acid, and carbonylated protein levels (all p < 0.05) compared to the other possibilities of intervention. In addition, PBMT‐sMF applied before and after WOD decreased creatine kinase activity at 24 hours and IL‐6 levels at 24 and 48 hours compared to placebo (p < 0.05). None of the participants reported any adverse events. PBMT‐sMF enhanced the performance of functional tests, decreased the levels of biochemical markers of muscle damage and inflammation, decreased oxidative stress, and increased antioxidant activity in CrossFit® athletes when applied before or after WOD.


  • Comparison between cryotherapy and photobiomodulation in muscle recovery: a systematic review and meta-analysis

    by João Vitor Ferlito, Marcos Vinicius Ferlito, Ernesto Cesar Pinto Leal-Junior, Shaiane Silva Tomazoni, Thiago De Marchi

    The purpose of this study is to compare the effect of photobiomodulation therapy (PBMT) and cryotherapy (CRT) on muscle recovery outcomes. These searches were performed in PubMed, PEDro, CENTRAL, and VHL (which includes the Lilacs, Medline, and SciELO database) from inception to June 2021. We included randomized clinical trials involved healthy human volunteers (> 18 years) underwent an intervention of PBMT and CRT, when used in both isolated form post-exercise. Standardized mean differences (SMD) or mean difference (MD) with 95% confidence interval were calculated and pooled in a meta-analysis for synthesis. The risk of bias and quality of evidence were assessed through Cochrane risk-of-bias tool and GRADE system. Four articles (66 participants) with a high to low risk of bias were included. The certainty of evidence was classified as moderate to very low. PBMT was estimated to improve the muscle strength (SMD = 1.73, CI 95% 1.33 to 2.13, I2 = 27%, p < 0.00001), reduce delayed onset muscle soreness (MD: − 25.69%, CI 95% − 34.42 to − 16.97, I2 = 89%, p < 0.00001), and lower the concentration of biomarkers of muscle damage (SMD = − 1.48, CI 95% − 1.93 to − 1.03, I2 = 76%, p < 0,00,001) when compared with CRT. There was no difference in oxidative stress and inflammatory levels. Based on our findings, the use of PBMT in muscle recovery after high-intensity exercise appears to be beneficial, provides a clinically important effect, and seems to be the best option when compared to CRT.


  • Open Access

    Effects of Photobiomodulation Therapy Combined with Static Magnetic Field in Severe COVID-19 Patients Requiring Intubation: A Pragmatic Randomized Placebo-Controlled Trial

    by Thiago De Marchi, Fabiano Frâncio, João Vitor Ferlito, Renata Weigert, Cristiane de Oliveira, Ana Paula Merlo, Délcio Luis Pandini, Bolivar Antônio Pasqual-Júnior, Daniela Giovanella, Shaiane Silva Tomazoni, et al.

    Purpose: We aimed to investigate the effects of photobiomodulation therapy combined with static magnetic field (PBMT-sMF) on the length of intensive care unit (ICU) stay and mortality rate of severe COVID-19 patients requiring invasive mechanical ventilation and assess its role in preserving respiratory muscles and modulating inflammatory processes. Patients and Methods: We conducted a prospectively registered, triple-blinded, randomized, placebo-controlled trial of PBMT-sMF in severe COVID-19 ICU patients requiring invasive mechanical ventilation. Patients were randomly assigned to receive either PBMT-sMF or a placebo daily throughout their ICU stay. The primary outcome was length of ICU stay, defined by either discharge or death. The secondary outcomes were survival rate, diaphragm muscle function, and the changes in blood parameters, ventilatory parameters, and arterial blood gases. Results: Thirty patients were included and equally randomized into the two groups. There were no significant differences in the length of ICU stay (mean difference, MD = − 6.80; 95% CI = − 18.71 to 5.11) between the groups. Among the secondary outcomes, significant differences were observed in diaphragm thickness, fraction of inspired oxygen, partial pressure of oxygen/fraction of inspired oxygen ratio, C-reactive protein levels, lymphocyte count, and hemoglobin (p < 0.05). Conclusion: Among severe COVID-19 patients requiring invasive mechanical ventilation, the length of ICU stay was not significantly different between the PBMT-sMF and placebo groups. In contrast, PBMT-sMF was significantly associated with reduced diaphragm atrophy, improved ventilatory parameters and lymphocyte count, and decreased C-reactive protein levels and hemoglobin count. Trial Registration Number (Clinical Trials.gov): NCT04386694.


  • Open Access

    Effects of photobiomodulation therapy combined with static magnetic field (PBMT-sMF) in patients with severe COVID-19 requiring intubation: a pragmatic randomized placebo-controlled trial

    by Thiago De Marchi, Fabiano Frâncio, João Vitor Ferlito, Renata Monteiro Weigert, Cristiane Aparecida de Oliveira, Ana Paula Merlo, Délcio Luis Pandini, Bolivar Antônio Pasqual Júnior, Daniela Frare Giovanella, Shaiane Silva Tomazoni, et al.

    Background: Photobiomodulation therapy (PBMT) when used isolated or combined with static magnetic field (PBMT-sMF) has been proven benefits on skeletal muscle increasing performance and reducing fatigue, increasing oxygen saturation, and modulating inflammatory process. However, it is unknown whether the effects observed with this therapy on respiratory muscles will be similar to the effects previously observed on skeletal muscles. Objective: We aimed to investigate whether PBMT-sMF is able to decrease the length of stay in the intensive care unit (ICU) and to reduce the mortality rate of patients with severe COVID-19 requiring invasive mechanical ventilation, increasing the respiratory function and modulating the inflammatory process. Methods: We conducted a prospectively registered, pragmatic, triple-blinded (patients, therapists and outcome assessors), randomized, placebo-controlled trial of PBMT-sMF in patients with severe COVID-19, requiring invasive mechanical ventilation, admitted to the ICU. Patients were randomly assigned to receive either PBMT-sMF (6 sites at the lower thorax – 189 J total, and 2 sites at the neck area – 63 J total) or placebo PBMT-sMF daily during all the ICU stay. The primary outcome was length of stay in the ICU defined by either discharge or death. The secondary outcomes were survival rate, muscle function of diaphragm, change in blood tests, change in mechanical ventilation parameters and change in arterial blood gas analysis. Results: A total of 30 patients underwent randomization (with 15 assigned to PBMT-sMF and 15 to placebo) and were analyzed. The length of stay in the ICU for the placebo group was 23.06 days while for the PBMT-sMF group was 16.26. However, there was no statistically difference between groups for the length of stay in the ICU (mean difference - MD = - 6.80; 95% CI = - 18.71 to 5.11). Regarding the secondary outcomes were observed statistically differences in favor of PBMT-sMF for diaphragm thickness, fraction of inspired oxygen, partial pressure of oxygen/fraction of inspired oxygen ratio, C-reactive protein, lymphocytes count, and hemoglobin (p<0.05). Conclusion: Among patients with severe COVID-19 requiring invasive mechanical ventilation, PBMT-sMF was not statistically different than placebo to the length of stay in the ICU. However, it is important to highlight that our sample size was underpowered to detect statistical differences to the primary outcome. In contrast, PBMT-sMF increased muscle function of diaphragm, improved ventilatory parameters, decreased C-reactive protein levels and hemoglobin count, and increased lymphocytes count.


  • Open Access

    Infrared Low-Level Laser Therapy (Photobiomodulation Therapy) before Intense Progressive Running Test of High-Level Soccer Players: Effects on Functional, Muscle Damage, Inflammatory, and Oxidative Stress Markers—A Randomized Controlled Trial

    by Shaiane Silva Tomazoni, Caroline dos Santos Monteiro Machado, Thiago De Marchi, Heliodora Leão Casalechi, Jan Magnus Bjordal, Paulo de Tarso Camillo de Carvalho, Ernesto Cesar Pinto Leal-Junior

    The effects of preexercise photobiomodulation therapy (PBMT) to enhance performance, accelerate recovery, and attenuate exercise-induced oxidative stress were still not fully investigated, especially in high-level athletes. The aim of this study was to evaluate the effects of PBMT (using infrared low-level laser therapy) applied before a progressive running test on functional aspects, muscle damage, and inflammatory and oxidative stress markers in high-level soccer players. A randomized, triple-blind, placebo-controlled crossover trial was performed. Twenty-two high-level male soccer players from the same team were recruited and treated with active PBMT and placebo. The order of interventions was randomized. Immediately after the application of active PBMT or placebo, the volunteers performed a standardized high-intensity progressive running test (ergospirometry test) until exhaustion. We analyzed rates of oxygen uptake (VO2 max), time until exhaustion, and aerobic and anaerobic threshold during the intense progressive running test. Creatine kinase (CK) and lactate dehydrogenase (LDH) activities, levels of interleukin-1β(IL-1-β), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α), levels of thiobarbituric acid (TBARS) and carbonylated proteins, and catalase (CAT) and superoxide dismutase (SOD) activities were measured before and five minutes after the end of the test. PBMT increased the VO2 max(both relative and absolute values—p<0.0467andp<0.0013, respectively), time until exhaustion (p<0.0043), time (p<0.0007) and volume (p<0.0355) in which anaerobic threshold happened, and volume in which aerobic threshold happened (p<0.0068). Moreover, PBMT decreased CK (p<0.0001) and LDH (p<0.0001) activities. Regarding the cytokines, PBMT decreased only IL-6 (p<0.0001). Finally, PBMT decreased TBARS (p<0.0001) and carbonylated protein levels (p<0.01) and increased SOD (p<0.0001)and CAT (p<0.0001) activities. The findings of this study demonstrate that preexercise PBMT acts on different functional aspects and biochemical markers. Moreover, preexercise PBMT seems to play an important antioxidant effect, decreasing exercise-induced oxidative stress and consequently enhancing athletic performance and improving postexercise recovery. This trial is registered with Clinicaltrials.gov NCT03803956.


  • Photobiomodulation therapy before futsal matches improves the staying time of athletes in the court and accelerates post-exercise recovery

    by Thiago De Marchi, Ernesto Cesar Pinto Leal-Junior, Kalvin Comin Lando, Fabiane Cimadon, Adriane Aver Vanin, Darlan Pase da Rosa, Mirian Salvador

    This study aimed to analyze PBMT effects on futsal player’s performance and recovery in a non-controlled field environment. It is a randomized, triple-blinded, placebo-controlled, crossover clinical trial. The research included six professional athletes and in each match phototherapy treatments were performed before matches (40 minutes), blood samples were collected before treatments, and samples immediately after the end of the matches and 48 h after. Furthermore, videos were analyzed to quantify the time athletes spent on the pitch and the distance they covered. PBMT was performed at 17 sites of each lower limb (40 mins before matches), employing a cluster with 12 diodes (4 laser diodes of 905 nm, 4 LEDs of 875 nm, and 4 LEDs of 640 nm, 30 J per site). The performance of the athlete could be quantified considering the time on the pitch and the distance covered; the biochemical markers evaluated were creatine kinase, lactate dehydrogenase, blood lactate, and oxidative damage to lipids and proteins. PBMT significantly increased the time of staying in the pitch and a significant improvement in all the biochemical markers evaluated. No statistically significant difference was found for the distance covered. Pre-exercise PBMT can enhance performance and accelerate recovery of high-level futsal players.